TGToshihiro Gi

Toshihiro Gi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toshihiro Gi has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Linking Coronary Microvascular Dysfunction to Cardiac Troponin Elevation in Transthyretin Amyloid Cardiomyopathy

    by Yosuke Suiko, Yunosuke Matsuura, Toshihiro Gi, Miyuki Ogata, Hiroki Tanaka, Soichi Komaki, Kohei Moribayashi, Takeshi Ideguchi, Atsushi Yamashita, Toshihiro Tsuruda, et al.

    Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is frequently accompanied by persistent elevation of high-sensitivity cardiac troponin T (hs-cTnT) and coronary microvascular dysfunction (CMD), yet their pathophysiological link remains incompletely defined. Aims: To identify the structural and functional correlates of hs-cTnT elevation in ATTR-CM. Methods and Results: We retrospectively studied 71 hospitalized patients with left ventricular hypertrophy (LVH) who underwent invasive physiological assessment of the left anterior descending artery, right heart catheterization, and endomyocardial biopsy as part of the etiological evaluation. ATTR-CM was histologically confirmed in 51 patients; the remaining 20 patients, who had no cardiac amyloidosis and alternative causes of LVH, served as a contextual reference group. The primary interpretation therefore focused on within-ATTR-CM associations. Coronary flow reserve (CFR), index of microcirculatory resistance (IMR), myocardial capillary density (MCD), and sampled transthyretin deposition were quantified and analysed in relation to hs-cTnT and haemodynamic and imaging parameters. Within the ATTR-CM cohort, higher hs-cTnT levels were independently associated with higher pulmonary artery wedge pressure (standardized β = 0.46, p = 0.0001), lower CFR (β = −0.26, p = 0.027), and lower MCD (β = −0.24, p = 0.037), but not with IMR or sampled histological transthyretin burden. Conclusions: In this selected invasive cohort with histologically confirmed ATTR-CM, higher hs-cTnT levels were independently associated with lower biopsy-derived MCD, impaired perfusion reserve, and elevated filling pressure, suggesting an integrated microvascular–haemodynamic substrate of persistent myocardial injury.

  • Sepsis‐Related Coronary Endarteritis With Multiple Coronary Artery Thrombi and Acute Myocardial Infarction

    by Toshihiro Gi, Hiroki Tanaka, Sayaka Moriguchi‐Goto, Kensaku Nishihira, Yujiro Asada, Koichi Kaikita, Atsushi Yamashita

  • Open Access

    Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage

    by Toshihiro Gi, Kaiyou Kai, Kotaro Shide, Eriko Nakamura, Nobuyuki Oguri, Murasaki Aman, Kazunari Maekawa, Sayaka Moriguchi-Goto, Michikazu Nakai, Kazuya Shimoda, et al.


  • Open Access

    Protease-activated receptor-1 expression in cytotrophoblasts and platelet-fibrin thrombus formation increase in placenta accreta spectrum

    by Murasaki Aman, Toshihiro Gi, Nobuyuki Ooguri, Eriko Nakamura, Kazunari Maekawa, Sayaka Moriguchi-Goto, Yuki Kodama, Shinji Katsuragi, Yujiro Asada, Yuichiro Sato, et al.

    Background: Placenta accreta spectrum (PAS) is characterized by abnormal trophoblastic invasion into the uterine myometrium and is a cause of postpartum hemorrhage and maternal death. Protease-activated receptor-1 (PAR-1) promotes various cellular actions, including invasion. Here, we analyzed the expression of PAR-1, platelet antigen, and fibrin in PAS. Methods: We analyzed 49 PAS cases (placenta accreta vera [accreta vera], 31 cases; placenta increta [increta], 8 cases; placenta percreta [percreta], 10 cases, classified by the degree of placental villous invasion) and 33 control cases. We immunohistochemically examined the expression of PAR-1, platelet glycoprotein (GP) IIb/IIIa, and fibrin. Results: The frequency of previous cesarean section was higher in the increta and percreta groups than in the control and accreta vera groups. PAR-1 expression in placental villi was weak and limited in extent in control cases, whereas immunoreactivity and staining density increased in increta and percreta. Immunofluorescence revealed PAR-1 expression in cytotrophoblasts of placental villi and in aggregated platelets. PAR-1 expression scores in cytotrophoblasts increased significantly with the degree of villous invasion (accreta vera, increta, percreta) compared with controls. The immunopositive areas for GPIIb/IIIa and fibrin were significantly larger in PAS groups than in controls. Furthermore, the immunopositive areas for platelets and fibrin were positively correlated with the PAR-1 expression score. Conclusion: These results indicate that PAR-1 may play a role in placental villous invasion and that a thrombogenic placental environment may influence PAR-1 activation.

  • Open Access

    Cathepsin G is associated with cerebral vascular injury in leukemia: A pathological insight into intracranial hemorrhage

    by Toshihiro Gi, Kaiyou Kai, Kotaro Shide, Eriko Nakamura, Nobuyuki Oguri, Murasaki Aman, Kazunari Maekawa, Sayaka Moriguchi-Goto, Kazuya Shimoda, Yohei Hisada, et al.

    Intracranial hemorrhage (ICH) is a fatal complication of leukemia; however, the mechanisms underlying its development, particularly central nervous system (CNS) involvement and vascular injury, remain unclear. This autopsy-based study investigated the histopathological features of cerebral vessels in leukemia and the expression of hemostasis-related factors in leukemia cells. Thirty-eight leukemia cases and 20 matched controls were included. A histopathological analysis of CNS tissues was performed to evaluate ICH, leukemia cell localization, and vascular injury. Immunohistochemistry was conducted to assess the expression of vascular endothelial growth factor (VEGF), cathepsin G, tissue-plasminogen activator, urokinase-plasminogen activator, urokinase plasminogen activator receptor, and tissue factor in leukemia cells. Vascular integrity and permeability were evaluated using stains for smooth muscle actin, collagen, fibrin, and von Willebrand factor. ICH was identified in 66% of leukemia cases and was associated with fatal brain herniation in 40%. CNS involvement was observed in 59% of cases, often without a clinical diagnosis. The leukemia cell infiltration of meninges and vascular walls was frequently associated with changes in smooth muscle cells and adventitial collagen. CNS vascular injury was frequently associated with ICH in the presence of leukemia cell infiltration. VEGF and urokinase-plasminogen activator were highly expressed in leukemia cells. VEGF was associated with meningeal invasion, while cathepsin G was predominantly expressed in myeloid leukemia and linked to vascular damage. These results suggest that the leukemia cell infiltration of cerebral vascular walls plays an important role in cerebral vessel injury and leukemia cell-related ICH via VEGF and cathepsin G expression. Key points: Leukemia cell infiltration into cerebral vascular walls is associated with vascular damage and intracranial hemorrhage in autopsy cases. The expression of VEGF and cathepsin G in leukemia may serve as markers of CNS involvement and cerebral vascular injury, respectively.

  • Open Access

    Inflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: Linking macrophage tissue factor and glycolysis

    by Kazunari Maekawa, Eriko Nakamura, Yoichi Saito, Yunosuke Matsuura, Toshihiro Gi, Kensaku Nishihira, Nobuyuki Oguri, Sayaka Moriguchi-Goto, Yuichiro Sato, Kinta Hatakeyama, et al.

    Background: The thrombogenic potential of cells within atherosclerotic plaques is critical in the formation of a coronary thrombus. We hypothesized that a combination of inflammatory and hypoxic stimuli enhances tissue factor (TF) expression and glycolysis in cells in atherosclerotic plaques and contributes to coronary thrombus formation. Aims: To identify TF- and hexokinase (HK)-II-expressing cells in coronary atherosclerotic plaques and thrombi and determine the effects of combined inflammatory and hypoxic stimuli and glycolysis on TF expression in peripheral blood mononuclear cell-derived macrophages. Methods: We immunohistochemically assessed TF and HK-II expression in stable (n = 20) and unstable (n = 24) human coronary plaques and aspirated acute coronary thrombi (n = 15). The macrophages were stimulated with tumor necrosis factor-α, interferon-γ, or interleukin-10 under normoxic (21% O2) or hypoxic (1% O2) conditions, and TF expression was assessed. Results: TF and HK-II expression were increased in unstable plaques compared with stable plaques. The number of CD68- and HK-II-immunopositive cells positively correlated with the number of TF-immunopositive cells. TF- and HK-II-expressing macrophages, which expressed M1- or M2-like markers, were involved in platelet-fibrin thrombus formation in ruptured plaques. The combination of inflammatory and hypoxic conditions additively augmented TF expression and procoagulant activity in the cultured macrophages. Inhibition of glycolysis with 2-deoxyglucose reduced the augmented TF expression and procoagulant activity. Conclusion: Combined inflammatory and hypoxic conditions in atherosclerotic plaques may markedly enhance procoagulant activity in macrophages and contribute to coronary thrombus formation following plaque disruption. Macrophage TF expression may be associated with glycolysis.


  • Open Access

    Neutrophil extracellular traps and thrombotic components across human coronary plaque progression: Association of intraplaque hemorrhage with NET formation

    by Eriko Nakamura, Saki Horiuchi, Kazunari Maekawa, Eiteru Kuroki, Toshihiro Gi, Nobuyuki Oguri, Murasaki Aman, Sayaka Moriguchi-Goto, Yujiro Asada, Atsushi Yamashita

    Neutrophil extracellular traps (NETs), fibrin, and von Willebrand factor (VWF) are present in acute coronary thrombotic plaques. This study aimed to investigate their distribution among the coronary atherosclerotic progression and the potential association between intraplaque hemorrhage and NET formation. Coronary artery sections from autopsy cases of non-cardiac death (n = 5, 37 sections) and ischemic heart disease (n = 11, 65 sections) were classified into six morphological groups and examined immunohistochemically. Effects of intraplaque hemorrhage related molecules on NETs formation were examined with human peripheral blood derived neutrophils. Neutrophils and citrullinated histone H3 (CitH3), a marker of NETs, were rarely observed except in thin-cap fibroatheromas and ruptured plaques. Fibrin deposition was detected from pathological intimal thickening onward and increased in thin-cap fibroatheromas and ruptured plaques. VWF deposition was mainly observed in necrotic cores and was abundant in ruptured plaques. Among non-ruptured plaques, CitH3- and fibrin-positive areas were significantly larger in plaques with intraplaque hemorrhage than in those without hemorrhage. In cultured human neutrophils, stimulation with hemin, ATP, ADP, or thrombin induced NET formation. These findings suggest that neutrophils, NETs, and platelets are not prominent features of early human coronary atherosclerotic lesions but become more evident with plaque progression and destabilization. In contrast, fibrin and VWF deposition can already be detected in earlier lesions. Intraplaque hemorrhage may further promote fibrin deposition, and NET-associated responses via erythrocyte-, platelets, coagulation-related molecules. Neutrophil accumulation and VWF deposition may predominantly accompany plaque rupture.


  • Open Access

    Expression of fibroblast activation protein-α in human deep venous thrombus

    by Nobuyuki Oguri, Toshihiro Gi, Eriko Nakamura, Eiji Furukoji, Hiroki Goto, Kazunari Maekawa, Atsushi B. Tsuji, Ryuichi Nishii, Murasaki Aman, Sayaka Moriguchi-Goto, et al.

    Background Fibroblast activation protein-α (FAP), a type-II transmembrane serine protease, is expressed during wound healing, in cancer-associated fibroblasts, and in chronic fibrosing diseases. However, its expression in deep vein thrombus (DVT) remains unclear. Therefore, in this study, we investigated FAP expression and localization in DVT. Methods First, we pathologically accessed aspirated thrombi of patients with DVT (n=14), classifying thrombotic areas as follows; fresh, cellular lysis, endothelialization, fibroblastic reaction. Endothelialization and fibroblastic reaction were defined as organizing reactions. We immunohistochemically examined FAP-expressed areas and expressed cells. Second, we analyzed FAP expression in cultured dermal fibroblasts. Results All the aspirated thrombi showed a mixture of at least three of the four thrombotic areas. Specifically, 83 % of aspirated thrombi showed fresh and organizing reactions within each thrombus. Immunohistochemical expression of FAP was restricted in organizing area. Further, FAP expression in the thrombi was mainly found in vimentin-positive or α-smooth muscle actin-positive fibroblasts in double immunofluorescence. Some CD163-positive macrophages also showed FAP expression. FAP mRNA and protein levels significantly increased in cultured fibroblasts with low- proliferative activity under 0.1% fetal bovine serum (FBS) than that in fibroblasts under 10% FBS. Fibroblasts cultured in 10% FBS showed a significant decrease in FAP mRNA levels following supplementation with hemin, but not with thrombin. Conclusions The heterogeneous composition of the venous thrombi suggests the existence of a multistep thrombus formation process in human DVT. Further, fibroblasts or myofibroblasts may express FAP in organizing process in DVT. FAP expression may increase in fibroblasts with low-proliferative activity.

  • Open Access

    Factor XI localization in human deep venous thrombus and function of activated factor XI on venous thrombus formation and hemostasis in rabbit

    by Nobuyuki Oguri, Toshihiro Gi, Eriko Nakamura, Kazunari Maekawa, Eiji Furukoji, Hoshimi Okawa, Sho Kouyama, Saki Horiuchi, Tatefumi Sakae, Minako Azuma, et al.

    Background: Novel anticoagulants targeting coagulation factor XI (FXI)/activated FXI (FXIa) are under development. However, whether FXI is present in human deep vein thrombosis (DVT) and whether FXIa and activated factor X (FXa) play different roles in venous thrombus formation and hemostasis remain unclear. This study aimed to determine the presence of FXI in DVT and the effects of direct oral FXIa and FXa inhibitors on venous thrombus formation and hemostasis in rabbits and mural thrombus formation in flow chamber system. Methods: We immunohistochemically assessed FXI localization in human aspirated DVT (n=15). Additionally, we compared thrombus formation induced by endothelial denudation and stenosis in jugular vein, and skin bleeding time and volume between rabbits treated with direct FXIa inhibitors (ONO-1600586) and FXa inhibitors (rivaroxaban). Ex vivo rabbit and human blood were perfused on a flow chamber under low shear rates (70/s). Result: FXI was localized in all DVT, predominantly in fibrin-rich areas. The FXI-immunopositive area in the non-organizing area was greater than that in the organizing area. Although FXIa and FXa inhibitors comparably inhibited venous thrombus formation, FXIa inhibitors did not affect bleeding time or volume in rabbits. FXIa or FXa inhibitors mildly or strongly inhibited fibrin formation at low shear rates respectively. Furthermore, the FXIa inhibitor suppressed human FXIa activity, thrombin generation, and fibrin formation during perfusion. Conclusion: The pathological findings of human DVT suggest FXI’s role in human DVT. FXIa inhibitors may inhibit less fibrin formation than FXa inhibitors, and may explain the minor role of FXIa in hemostasis. Essential: Presence of factor XI (FXI) in venous thrombus and less bleeding in its inhibition are unclear. We assessed FXI localization in deep vein thrombosis (DVT) and function of FXIa in rabbit. FXI localized in human DVT that provide a rationale for FXI inhibition in human DVT. FXIa inhibitor inhibited less fibrin formation than factor Xa inhibitor under low-shear rate.

  • Open Access

    Very Late Stent Thrombosis Complicating Immune Thrombocytopenia

    by Hisanobu Shimazu, Yunosuke Matsuura, Kohei Moribayashi, Toshihiro Gi, Yosuke Suiko, Hiroki Tanaka, Soichi Komaki, Tetsunori Ishikawa, Atsushi Yamashita, Koichi Kaikita